DARWEEN BIOSCIENCE
Business purpose.
Développement de technologies pour le design et la production de protéines Recombinantes.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Research and experimental development on biotechnology (72.11Z)
- Sector
- Scientific research and development
- Headcount
- 1 to 2 employees
- Created
- 13 Sep 2023
- Share capital
- 1,447.46 EUR
- Registered with the trade register
- 13 Sep 2023
- Financial year end
- 31/12
- Establishments
- 1
Directors
- Cyril Julien Christophe VERAN 45 years old, 09/1981 President de SAS
Other companies at the same address
More than 500 other company head offices are registered at this address.
Establishments
Financial strength
Financial score
Cannot be computed, not enough data
Confidence: low
formula fin-1.0
Legal score
66 / 100 B
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (3.2 years)
- 6.3 out of 20
- Accounts filed recently
- 0.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale des bureaux d'études techniques, des cabinets d'ingénieurs-conseils et des sociétés de conseils du 15 décembre 1987.
IDCC 1486 · in force, extended · 1 establishment · declared in July 2026
Legal notices
-
Amendment 22 Mar 2026
- Court :
- Greffe du Tribunal des Activités Economiques de Paris
- Amendment :
- modification survenue sur le capital (augmentation)
BODACC B n 20260056, annonce n 2997 · Proof of publication (PDF)
-
Amendment 16 Oct 2025
- Court :
- Greffe du Tribunal des Activités Economiques de Paris
- Amendment :
- modification survenue sur le capital (augmentation)
BODACC B n 20250199, annonce n 2653 · Proof of publication (PDF)
-
Amendment 28 Jul 2024
- Court :
- Greffe du Tribunal de Commerce de Paris
- Amendment :
- modification survenue sur le capital (augmentation)
BODACC B n 20240145, annonce n 3022 · Proof of publication (PDF)
-
Incorporation 4 Oct 2023
- Court :
- Greffe du Tribunal de Commerce de Paris
BODACC A n 20230191, annonce n 1030 · Proof of publication (PDF)
Filings and accounts
- Formality 8 Oct 2025
Change history
- employee_range NN → 01 4 Nov 2026
- employee_range NN → 01 3 Nov 2026
- officer_appointed (empty) → President de SAS 10 Oct 2026
- capital 100.00 → 1000.00 2 Oct 2026
- capital 1447.46 → 100.00 1 Oct 2026
- capital 1551.72 → 1447.46 1 Oct 2026
- registered_address (empty) → 60 rue François Ier 75008 Paris 1 Oct 2026
- capital (empty) → 1551.72 1 Oct 2026
Frequently asked questions about DARWEEN BIOSCIENCE
- What is the SIREN number of DARWEEN BIOSCIENCE?
- The SIREN number of DARWEEN BIOSCIENCE is 979667250. Its intra-community VAT number is FR23979667250.
- Where is the head office of DARWEEN BIOSCIENCE?
- Head office address: 60 RUE FRANCOIS IER, 75008 PARIS.
- When was DARWEEN BIOSCIENCE founded?
- DARWEEN BIOSCIENCE was founded on 13 Sep 2023.
- What does DARWEEN BIOSCIENCE do?
- Its declared main activity is: Research and experimental development on biotechnology (NAF code 72.11Z).
- Who runs DARWEEN BIOSCIENCE?
- The officer listed in the register is Cyril Julien Christophe VERAN (President de SAS).
- How many employees does DARWEEN BIOSCIENCE have?
- The declared headcount is 1 to 2 employees. Insee data for 2024.
- Is DARWEEN BIOSCIENCE subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.